OLYMPIA – The Washington State Liquor and Cannabis Board (WSLCB) today issued the state’s first license to produce, process and possess marijuana for research purposes. The license was issued to Verda Bio Research in Seattle, who are conducting research on cannabinoid based therapeutics.
“This is an important milestone for Washington’s marijuana industry,” said Director Rick Garza. “We’re hopeful that the research will assist policy makers as we grapple with this emerging industry.”
Research licensees are permitted to produce, process and possess marijuana for limited research purposes: to test chemical potency and composition levels; conduct clinical investigations of marijuana-derived drug products; conduct research on the efficacy and safety of administering marijuana as part of medical treatment; and to conduct genomic or agricultural research. Applicants are investigated and must meet the same criteria as other marijuana businesses including security, distance from restricted areas, traceability, etc.
In addition to the above requirements applications are also vetted through an independent third-party scientific reviewer. The role of the reviewer is to assess the project’s quality, study design, value, and/or impact. They also review whether applicants have the appropriate personnel, expertise, facilities/infrastructure, funding, and human/animal/other federal approvals in place to successfully conduct the project.
Research projects must pass both the scientific review and licensing requirements before the application is approved.
Contact: Brian Smith, WSLCB Communications, (360) 664-1774
Jessica Tonani, Verda Bio Research, (206) 669-4402
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
The New York State Department of Labor has released new guidance regarding legalized recreational marijuana use and the workplace. According to that new guidance, employers must cite “articulable symptoms of impairment” in almost any effort to take action against an employee due to marijuana use. That means an employer must provide “objectively observable” evidence that…
Vermont’s Cannabis Control Board estimates that spending on recreational marijuana in Vermont could reach $225 million annually by 2025, which would translate to nearly $46 million in new state taxes. The figures are just some of the news from a highly anticipated report the board released last Friday. The 64-page document lays the groundwork for…
The initiative, promoted by independent legislator Zoila Rosa Volio, received the affirmative vote of 33 legislators, while 13 voted against it, after extensive discussion and the opposition of several legislators, mainly from the Restauración Nacional, Nueva República, Integración Nacional (PIN), and independent Shirley Díaz. The plan focuses on authorizing the production of cannabis plants, both…
A package of spending bills unveiled by a U.S. Senate committee on Monday evening does not include language that had prohibited D.C. from legalizing the sale of marijuana for the last six years, lifting a significant roadblock to the city’s plans to legalize and license dispensaries to sell the drug for recreational use. Earlier this summer the House of…